Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Damour O, Hua SZ, Lasne F, et al: Cytotoxicity evaluation of antiseptics and antibiotics on cultured human fibroblasts and keratinocytes. Burns 1992; 18:479–485
Gasset AR, Ishii Y: Cytotoxicity of chlorhexidine. Can J Ophthalmol 1975; 10:98–100
Faddis D, Daniel D, Boyer J: Tissue toxicity of antiseptic solutions. A study of rabbit articular and periarticular tissues. J Trauma 1977; 17:895–897
Kimbrough RD: Review of the toxicity of hexachlorophene. Arch Environ Health 1971; 23:119–122
Eaglstein WH, Falanga V: Chronic wounds. Surg Clin North Am 1997; 77:689–700
Murray PR, Rosenthal KS, Kobayashi GS, et al: Sterilization, disinfection, and antisepsis. In: Murray PR, Rosenthal KS, Kobayashi GS, Pfaller MA (eds) Medical Microbiology, 3rd edn. St. Louis: Mosby. 1988; pp 74–78
Disinfectants and preservatives. In: Kathleen Parfitt (ed) Martindale — The Complete Drug Reference, 32nd edn. London: Pharmaceutical Press. 1999; pp 1116–1117
Lineaweaver W, McMorris S, Soucy D, et al: Cellular and bacterial Toxicities of topical antimicrobials. Plast Reconstr Surg 1985; 75:394–396
O'Toole EA, Goel M, Woodley DT: Hydrogen peroxide inhibits human keratinocyte migration. Dermatol Surg 1996; 22:525–529
Tur E, Bolton L, Constantine BE: Topical hydrogen peroxide treatment of ischemic ulcers in the guinea pig: blood recruitment in multiple skin sites. J Am Acad Dermatol 1995; 33:217–221
Christensen OB, Anehus S: Hydrogen peroxide cream: an alternative to topical antibiotics in the treatment of impetigo contagiosa. Acta Derm Venereol (Stockh) 1994; 74:460–462
Disinfectants and preservatives. In: Kathleen Parfitt (ed) Martindale — The Complete Drug Reference, 32nd edn. London: Pharmaceutical Press. 1999; pg 1123
Southwood T, Lamb CM, Freeman J: Ingestion of potassium permanganate crystals by a three-year-old boy. Med J Aust 1987; 146:639–640
Middleton SJ, Jacyna M, McClaren D, et al: Haemorrhagic pancreatitis — a cause of death in severe potassium permanganate poisoning. Postgrad Med J 1990; 66:657–658
Rutala WA: Antisepsis, disinfection, and sterilization in hospitals and related institutions. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH (eds) Manual of Clinic Microbiology, 6th edn. Washington: ASM Press. 1995; pp 227–245
Disinfectants and preservatives. In: Kathleen Parfitt (ed): Martindale — The Complete Drug Reference, 32nd edn. London: Pharmaceutical Press. 1999; pp 1123–1124
Georgiade NG, Harris WA: Open and closed treatment of burns with povidone iodine. Plast Reconstr Surg 1973; 52:640–644
Burks RI: Povidone-iodine solution in wound treatment. Phys Ther 1998; 78:212–218
Smoot EC 3rd, Kucan JO, Roth A, et al: In vitro toxicity testing for antibacterials against human keratinocytes. Plast Reconstr Surg 1991; 87:917–924
Cooper ML, Laxer JA, Hansbrough JF: The cytotoxic effects of commonly used topical antimicrobial agents on human fibroblasts and keratinocytes. J Trauma 1991; 31:775–784
Kozuka T: Patch testing to exclude allergic contact dermatitis caused by povidone-iodine. Dermatology 2002; 204:96–98
Nishioka K, Seguchi T, Yasuno H, et al: The results of ingredient patch testing in contact dermatitis elicited by povidone-iodine preparations. Contact Dermatitis 2000; 42:90–94
Erdmann S, Hertl M, Merk HF: Allergic contact dermatitis from povidone-iodine. Contact Dermatitis 1999; 40:331–332
Niedner R: Cytotoxicity and sensitization of povidone-iodine and other frequently used unti-infective agents. Dermatology 1997; 195:89–92
Lopez Saez MP, de Barrio M, Zubeldia JM, et al: Acute lgE-mediated generalized urticaria-angioedema after application of povidone-iodine. Allergol Immunopathol (Madr) 1998; 26 23–26
Waran KD, Munsick RA: Anaphylaxis from povidone-iodine. Lancet 1995; 345:1506
Pierard-Franchimont C, Paquet P, Arrese JE, et al: Healing rate and bacterial necrotizing vasculitis in venous leg ulcers. Dermatology 1997; 194:383–387
Fumal I, Braham C, Paquet P, et al: The beneficial toxicity paradox of antimicrobials in leg ulcer healing impaired by a polymicrobial flora: a proof of concept study. Dermatology 2002; 204:70–74
O'Meara SM, Cullum NA, Majid M, Sheldon TA: Systemic review of antimicrobial agents used for chronic wounds. Br J Surg 2001; 88:4–21
Donohue K, Rausch H, Falanga V: Wound bed preparation. In: Rovee DT, Maibach HI (eds) The Epidermis in Wound Healing. Boca Raton, CRC Press. 2004; pp 255–264.
Kirsner RS, Martin LK, Drosou A: Wound microbiology and the use of antibacterial agents. In: Rovee DT, Maibach HI (eds) The Epidermis in Wound Healing. Boca Raton: CRC Press. 2004; pp 155–182.
Dychdala GR: Chlorine and chlorine compounds. In: Block SS (ed) Disinfection, Sterilization and Preservation. 4th edn. Philadelphia: Lea & Febiger. 1991; pp 131–151
Leaper DJ: Eusol: Still awaiting proper clinical trials. Br Med J 1992; 304:930–931
Mertz PM, Alvarez OM, Smerbeck RV, et al: A new in vivo model for the evaluation of topical antiseptics on superficial wounds. Arch Dermatol 1984; 120:58–62
Brennan SS, Foster ME, Leaper DJ: Antiseptic toxicity in wound healing by secondary intention. J Hosp Infect 1986; 8:263–267
Brennan SS, Leaper DJ: The effect of antiseptics on the healing wound: a study using the rabbit ear chamber. Br J Surg 1985; 72:780–782
Spadaro JA, Chase SE, Webster DA: Bacterial inhibition by electrical activation of percutaneous silver implants. J Biomed Mater Res 1986; 20:565–577
Lansdown AB: Silver I. Its antibacterial properties and mechanism of action. J Wound Care 2002; 11:125–130
Deitch EA, Marino AA, Gillespie TE, et al: Silver-nylon: a new antimicrobial agent. Antimicrob Agents Chemother 1983; 23:356–359
Colmano G, Edwards SS, Barranco SD: Activation of antibacterial silver coatings on surgical implants by direct current: preliminary studies in rabbits. Am J Vet Res 1980; 41:964–966
Tsai WC, Chu CC, Chiu SS, et al: In vitro quantitative study of newly made antibacterial braided nylon sutures. Surg Gynecol Obstet 1987; 165:207–211
Chu CC, Tsai WC, Yao JY, et al: Newly made antibacterial braided nylon sutures. I. In vitro qualitative and in vivo preliminary biocompatibility study. J Biomed Mater Res 1987; 21:1281–1300
Wysor MS, Zollinhofer RE: On the mode of action of silver sulphadiazine. Pathol Microbiol 1972; 38:296–308
Modak SM, Fox CL Jr: Binding of silver sulfadiazine to the cellular components of Pseudomonas aeruginosa. Biochem Pharmacol 1973; 22:2391–2404
Lowbury EJ, Babb JR, Bridges K, et al: Topical chemoprophylaxis with silver sulphadiazine and silver nitrate chlorhexidine creams: emergence of sulphonamide-resistant. Gram-negative bacilli. Br Med J 1976; 1:493–496
Fuller FW, Parrish M, Nance FC: A review of the dosimetry of 1% silver sulphadiazine cream in burn wound treatment. J Burn Care Rehabil 1994; 15:213–223
Wlodkowski TJ, Rosenkranz HS: Antifungal activity of silver sulphadiazine. Lancet 1973; 2:739–740
Wright JB, Lam K, Hansen D, et al: Efficacy of topical silver against fungal burn wound pathogens. Am J Infect Control 1999; 27:344–350
Hidalgo E, Dominguez C: Study of cytotoxicity mechanisms of silver nitrate in human dermal fibroplasts. Toxicol Lett 1998; 98:169–179
Hidalgo E, Bartolome R, Barroso C, et al: Silver nitrate: antimicrobial activity related to cytotoxicity in cultured human fibroblasts. Skin Pharmacol Appl Skin Physiol 1998; 11:140–151
McCauley RL, Li YY, Poole B, et al: Differential inhibition of human basal keratinocyte growth to silver sulfadiazine and mafenide acetate. J Surg Res 1992; 52:276–285
Antibacterials. In: Kathleen Parfitt (ed) Martindale — The Complete Drug Reference. 32nd edn. London: Pharmaceutical Press. 1999; pp 247, 248
Monafo WW, Freedman B: Topical therapy for burns. Surg Clin North Am 1987; 67:133–145
Pirnay JP, De Vos D, Cochez C, et al: Molecular epidemiology of Pseudomonas aeruginosa colonization in a burn unit: persistence of a multidrug-resistant clone and a silver sulfadiazine-resistant clone. J Clin Microbiol 2003; 41:1192–1202
Yoshida T, Ohura T, Sugihara T, et al: Clinical efficacy of silver sulfadiazine (AgSD: Geben cream) for ulcerative skin lesions infected with MRSA. Jpn J Antibiot 1997; 50:39–44
Marone P, Monzillo V, Perversi L, et al: Comparative in vitro activity of silver sulfadiazine, alone and in combination with cerium nitrate, against staphylococci and gram-negative bacteria. J Chemother 1998; 10:17–21
Degreef H, Dooms-Goossens A: Patch testing with silver sulfadiazine cream. Contact dermatitis 1985; 12:33–37
McKenna SR, Latenser BA, Jones LM, et al: Serious silver sulphadiazine and mafenide acetate dermatitis. Burns 1995; 21:310–312
Fuller FW, Engler PE: Leukopenia in non-septic burn patients receiving topical 1% silver sulfadiazine cream therapy: a survey. J Burn Care Rehabil 1988; 9:606–609
Thomson PD, Moore NP, Rice TL, et al: Leukopenia in acute thermal injury: evidence against topical silver sulfadiazine as the causative agent. J Burn Care Rehabil 1989; 10:418–420
Chou TD, Gibran NS, Urdahl K, et al: Methemoglobinemia secondary to topical silver nitrate therapy — a case report. Burns 1999; 25:549–552
Geronemus RG, Mertz PM, Eaglstein WH: Wound healing. The effects of topical antimicrobial agents. Arch Dermatol 1979; 115:1311–1314
Glesinger R, Cohen AD, Bogdanov-Berezovsky A, et al: A randomized controlled trial of silver sulfadiazine, biafine, and saline-soaked gauze in the treatment of superficial partial-thickness burn wounds in pigs. Acad Emerg Med 2004; 11:339–342
Watcher MA, Wheeland RG: The role of topical agents in the healing of full thickness wounds. J Dermatol Surg Oncol 1989; 15:1188–1195
Phillips TJ, Dover JS: Leg ulcers. J Am Acad Dermatol 1991; 25:965–987
Blair SD, Backhouse CM, Wright DDI, et al: Do dressings influence the healing of chronic venous ulcers? Phlebology 1988; 3:129–134
Bishop JB, Phillips LG, Mustoe TA, et al: A prospective randomized evaluator-blinded trial of two potential wound healing agents for the treatment of venous stasis ulcers. J Vasc Surg 1992; 16:251–257
Van Den Hoogenband HM: Treatment of leg ulcers with split-thickness skin grafts. J Dermatol Surg Oncol 1984; 10:605–608
Niedner R, Schopf E: Wound infections and antibacterial therapy. In: Westerhof W (ed) Leg Ulcers: Diagnosis and Treatment. Amsterdam: Elsevier. 1993; pp 293–303
Saji M, Taguchi S, Uchiyama K, et al: Efficacy of gentian violet in the eradication of methicillin-resistant Staphylococcus aureus from skin lesions. J Hosp Infect 1995; 31:225–228
Niedner R, Schopf E: Inhibition of wound healing by antiseptics. Br J Dermatol 1986; 115[Suppl]:41–44
Mobacken H: Gentian violet and wound repair. J Am Acad Dermatol 1986; 15:1303
Bjornberg A, Mobacken H: Necrotic skin reactions caused by 1% gentian violet and brilliant green. Acta Derm Vevereol 1972; 52:55–60
Mobacken H, Zederfeldt B: Influence of a cationic triphenylmethane dye on granulation tissue growth in vivo. An experimental study in rats. Acta Derm Venereol 1973; 53:167–172
Balabanova M, Popova L, Tchipeva R: Dyes in dermatology. Clin Dermatol 2003; 21:2–6
Disinfectants and preservatives. In: Kathleen Parfitt (ed) Martindale — The Complete Drug Reference, 32nd edn. London: Pharmaceutical Press. 1999; pp 1111–1112
Goldwyn RM: Carl August Burow. Plast Reconstr Surg 1984; 73:687–690
Wilkinson JD: Formulary of topical applications. In: Champion RH, Burton JL, Ebling FJC (eds) Rook/Wilkinson/Ebling Textbook of Dermatology. 5th edn. Oxford: Blackwell Scientific Publications. 1992; pp 3122
Supplementary drugs and other substances. In: Kathleen Parfitt (ed) Martindale — The Complete Drug Reference, 32nd edn. London: Pharmaceutical Press. 1999; pp 1547
Thorp MA, Kruger J, Oliver S, et al: The antibacterial activity of acetic acid and Burow's solution as topical otologic preparations. J Laryngol Otol 1998; 112:925–928
Stern JC, Shah MK, Lucente FE: In vitro effectiveness of 13 agants in otomycosis and review of the literature. Laryngoscope 1988; 98:1173–1177
Clayton MI, Osborne JE, Rutherford D, et al: A double-blind, randomized, prospective trial of a topical antiseptic versus a topical antibiotic in the treatment of otorrhoea. Clin Otolaryngol 1990; 15:7–10
Rights and permissions
Copyright information
© 2005 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
(2005). Topical Antibacterial Agents. In: Wound Healing and Ulcers of the Skin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-26761-1_11
Download citation
DOI: https://doi.org/10.1007/3-540-26761-1_11
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-21275-1
Online ISBN: 978-3-540-26761-4
eBook Packages: MedicineMedicine (R0)